Specify a stock or a cryptocurrency in the search bar to get a summary
Tasly Pharmaceutical Group Co Ltd
600535Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally. It provides cardiovascular, anti-tumor, cold and fever, liver disease treatment, and other disease solutions. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China. Address: No. 2, Puji East Road, Tianjin, China, 300410
Analytics
WallStreet Target Price
124.4 CNYP/E ratio
25.3898Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600535
Dividend Analytics 600535
Dividend growth over 5 years
-18 %Continuous growth
–Payout Ratio 5 years average
-7 %Dividend History 600535
Stock Valuation 600535
Financials 600535
Results | 2019 | Dynamics |